Details of the Drug Inactive Ingredient (DIG)
| General Information of DIG (ID: E0R4JL) | |||||
|---|---|---|---|---|---|
| DIG Name | Polysorbate 80 | ||||
| DIG Function | Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent | ||||
| Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
|---|---|---|---|---|---|---|
| ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
| Minocycline | API Info | 
	Streptococcus bacterial infection [ICD-11: 1C41] | [1] | |||
| Valacyclovir | API Info | 
	Herpes zoster [ICD-11: 1E91] | [2] | |||
| Metronidazole | API Info | 
	Amebiasis [ICD-11: 1A36] | [3] | |||
| Ribavirin | API Info | 
	Viral hepatitis [ICD-11: 1E51] | [4] | |||
| Famciclovir | API Info | 
	Genital herpes [ICD-11: 1A94] | [5] | |||
| Ethambutol | API Info | 
	Pulmonary tuberculosis [ICD-11: 1B10] | [6] | |||
| Ciprofloxacin | API Info | 
	Endocarditis [ICD-11: 1B12] | [7] | |||
| Cefprozil | API Info | 
	Streptococcus bacterial infection [ICD-11: 1C41] | [8] | |||
| Chloroquine | API Info | 
	Malaria [ICD-11: 1F40] | [9] | |||
| Entecavir | API Info | 
	Viral hepatitis [ICD-11: 1E51] | [10] | |||
| Ritonavir | API Info | 
	Human immunodeficiency virus infection [ICD-11: 1C60] | [11] | |||
| Lamivudine | API Info | 
	Human immunodeficiency virus infection [ICD-11: 1C60] | [12] | |||
| Primaquine | API Info | 
	Malaria [ICD-11: 1F40] | [13] | |||
| Valganciclovir | API Info | 
	Cytomegalovirus infection [ICD-11: 1D82] | [14] | |||
| Hydroxychloroquine | API Info | 
	Malaria [ICD-11: 1F40] | [15] | |||
| Moxifloxacin | API Info | 
	Streptococcus bacterial infection [ICD-11: 1C41] | [16] | |||
| Abacavir | API Info | 
	Human immunodeficiency virus infection [ICD-11: 1C60] | [17] | |||
| Mefloquine | API Info | 
	Malaria [ICD-11: 1F40] | [18] | |||
| ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
| Bicalutamide | API Info | 
	Prostate cancer [ICD-11: 2C82] | [19] | |||
| Exemestane | API Info | 
	Breast cancer [ICD-11: 2C60] | [20] | |||
| Methotrexate | API Info | 
	Breast cancer [ICD-11: 2C60] | [21] | |||
| Trametinib | API Info | 
	Melanoma [ICD-11: 2C30] | [22] | |||
| Nystatin | API Info | 
	Acute lymphoblastic leukemia [ICD-11: 2B33] | [23] | |||
| Venetoclax | API Info | 
	Chronic lymphocytic leukaemia [ICD-11: 2A82] | [24] | |||
| Lapatinib | API Info | 
	Breast cancer [ICD-11: 2C60] | [25] | |||
| Anastrozole | API Info | 
	Breast cancer [ICD-11: 2C60] | [26] | |||
| Pazopanib | API Info | 
	Renal cell carcinoma [ICD-11: 2C90] | [27] | |||
| ICD Disease Classification 03 | Blood/blood-forming organ disease | Click to Show/Hide | ||||
| Eltrombopag | API Info | 
	Thrombocytopenia [ICD-11: 3B64] | [28] | |||
| ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
| Cetirizine | API Info | 
	Allergy [ICD-11: 4A80] | [29] | |||
| ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
| Fenofibrate | API Info | 
	Hypertriglyceridaemia [ICD-11: 5C80] | [30] | |||
| Atorvastatin | API Info | 
	Hyperlipidaemia [ICD-11: 5C8Z] | [31] | |||
| Phentermine | API Info | 
	Obesity [ICD-11: 5B81] | [32] | |||
| Glipizide | API Info | 
	Diabetes mellitus [ICD-11: 5A10] | [33] | |||
| Glimepiride | API Info | 
	Diabetes mellitus [ICD-11: 5A10] | [34] | |||
| Lovastatin | API Info | 
	Hypertriglyceridaemia [ICD-11: 5C80] | [35] | |||
| Paricalcitol | API Info | 
	Hyperparathyroidism [ICD-11: 5A51] | [36] | |||
| Metformin | API Info | 
	Diabetes mellitus [ICD-11: 5A10] | [37] | |||
| Fenofibric acid | API Info | 
	Dyslipidaemia [ICD-11: 5C81] | [38] | |||
| Benzphetamine | API Info | 
	Obesity [ICD-11: 5B81] | [39] | |||
| Nateglinide | API Info | 
	Diabetes mellitus [ICD-11: 5A10] | [40] | |||
| Ergocalciferol | API Info | 
	Hypoparathyroidism [ICD-11: 5A50] | [41] | |||
| Probenecid | API Info | 
	Hyperuricaemia [ICD-11: 5C55] | [42] | |||
| Gemfibrozil | API Info | 
	Hypertriglyceridaemia [ICD-11: 5C80] | [43] | |||
| Cholecalciferol | API Info | 
	Hyperparathyroidism [ICD-11: 5A51] | [44] | |||
| Mifepristone | API Info | 
	Cushing syndrome [ICD-11: 5A70] | [45] | |||
| Omega-3 carboxylic acid | API Info | 
	Hypertriglyceridaemia [ICD-11: 5C80] | [46] | |||
| Miglitol | API Info | 
	Diabetic complication [ICD-11: 5A2Y] | [47] | |||
| ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
| Bupropion | API Info | 
	Nicotine dependence [ICD-11: 6C4A] | [48] | |||
| Alprazolam | API Info | 
	Anxiety disorder [ICD-11: 6B00] | [49] | |||
| Lamotrigine | API Info | 
	Bipolar disorder [ICD-11: 6A60] | [50] | |||
| Fluoxetine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [51] | |||
| Duloxetine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [52] | |||
| Venlafaxine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [53] | |||
| Sertraline | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [54] | |||
| Amitriptyline | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [55] | |||
| Olanzapine | API Info | 
	Schizophrenia [ICD-11: 6A20] | [56] | |||
| Hydroxyzine | API Info | 
	Anxiety disorder [ICD-11: 6B00] | [57] | |||
| Ziprasidone | API Info | 
	Schizophrenia [ICD-11: 6A20] | [58] | |||
| Paroxetine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [59] | |||
| Quetiapine | API Info | 
	Schizophrenia [ICD-11: 6A20] | [60] | |||
| Cyclobenzaprine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [61] | |||
| Mirtazapine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [62] | |||
| Imipramine | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [63] | |||
| Prochlorperazine | API Info | 
	Schizophrenia [ICD-11: 6A20] | [64] | |||
| Desipramine | API Info | 
	Attention deficit hyperactivity disorder [ICD-11: 6A05] | [65] | |||
| Fluvoxamine | API Info | 
	Obsessive-compulsive disorder [ICD-11: 6B20] | [66] | |||
| Fluphenazine | API Info | 
	Schizophrenia [ICD-11: 6A20] | [67] | |||
| Trazodone | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [68] | |||
| Escitalopram | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [69] | |||
| Citalopram | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [70] | |||
| Protriptyline | API Info | 
	Major depressive disorder [ICD-11: 6A70] | [71] | |||
| Perphenazine | API Info | 
	Schizophrenia [ICD-11: 6A20] | [72] | |||
| Naltrexone | API Info | 
	Alcohol dependence [ICD-11: 6C40] | [73] | |||
| ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
| Zolpidem | API Info | 
	Insomnia [ICD-11: 7A00] | [74] | |||
| Eszopiclone | API Info | 
	Insomnia [ICD-11: 7A00] | [75] | |||
| ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
| Acetaminophen | API Info | 
	Anaesthesia [ICD-11: 8E22] | [76] | |||
| Morphine | API Info | 
	Anaesthesia [ICD-11: 8E22] | [77] | |||
| Gabapentin | API Info | 
	Focal seizure [ICD-11: 8A68] | [78] | |||
| Oxycodone | API Info | 
	Anaesthesia [ICD-11: 8E22] | [79] | |||
| Valproic acid | API Info | 
	Epilepsy [ICD-11: 8A60] | [80] | |||
| Ropinirole | API Info | 
	Parkinsonism [ICD-11: 8A00] | [81] | |||
| Levetiracetam | API Info | 
	Focal seizure [ICD-11: 8A68] | [82] | |||
| Tramadol | API Info | 
	Anaesthesia [ICD-11: 8E22] | [83] | |||
| Topiramate | API Info | 
	Focal seizure [ICD-11: 8A68] | [84] | |||
| Oxymorphone | API Info | 
	Anaesthesia [ICD-11: 8E22] | [85] | |||
| Galantamine | API Info | 
	Alzheimer disease [ICD-11: 8A20] | [86] | |||
| Oxcarbazepine | API Info | 
	Epilepsy [ICD-11: 8A60] | [87] | |||
| Hydromorphone | API Info | 
	Anaesthesia [ICD-11: 8E22] | [88] | |||
| Hydrocodone | API Info | 
	Anaesthesia [ICD-11: 8E22] | [89] | |||
| Donepezil | API Info | 
	Alzheimer disease [ICD-11: 8A20] | [90] | |||
| Tiagabine | API Info | 
	Epilepsy [ICD-11: 8A60] | [91] | |||
| Zolmitriptan | API Info | 
	Migraine [ICD-11: 8A80] | [92] | |||
| Entacapone | API Info | 
	Parkinsonism [ICD-11: 8A00] | [93] | |||
| Sumatriptan | API Info | 
	Migraine [ICD-11: 8A80] | [94] | |||
| Deutetrabenazine | API Info | 
	Huntington disease [ICD-11: 8A01] | [95] | |||
| Ticlopidine | API Info | 
	Cerebral stroke [ICD-11: 8B11] | [96] | |||
| Dimethyl fumarate | API Info | 
	Multiple sclerosis [ICD-11: 8A40] | [97] | |||
| ICD Disease Classification 09 | Visual system disease | Click to Show/Hide | ||||
| Dextromethorphan | API Info | 
	Allergic conjunctivitis [ICD-11: 9A60] | [98] | |||
| ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
| Diphenhydramine | API Info | 
	Meniere disease [ICD-11: AB31] | [99] | |||
| Cephalexin | API Info | 
	Acute otitis media [ICD-11: AB00] | [100] | |||
| ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
| Diltiazem | API Info | 
	Essential hypertension [ICD-11: BA00] | [101] | |||
| Aspirin | API Info | 
	Myocardial infarction [ICD-11: BA41] | [102] | |||
| Metoprolol | API Info | 
	Essential hypertension [ICD-11: BA00] | [103] | |||
| Verapamil | API Info | 
	Essential hypertension [ICD-11: BA00] | [104] | |||
| Caffeine | API Info | 
	Orthostatic hypotension [ICD-11: BA21] | [105] | |||
| Felodipine | API Info | 
	Essential hypertension [ICD-11: BA00] | [106] | |||
| Amlodipine | API Info | 
	Angina pectoris [ICD-11: BA40] | [107] | |||
| Propafenone | API Info | 
	Ventricular tachyarrhythmia [ICD-11: BC71] | [108] | |||
| Benazepril | API Info | 
	Essential hypertension [ICD-11: BA00] | [109] | |||
| Carvedilol | API Info | 
	Congestive heart failure [ICD-11: BD10] | [110] | |||
| Spironolactone | API Info | 
	Congestive heart failure [ICD-11: BD10] | [111] | |||
| Labetalol | API Info | 
	Essential hypertension [ICD-11: BA00] | [112] | |||
| Isosorbide mononitrate | API Info | 
	Angina pectoris [ICD-11: BA40] | [113] | |||
| Irbesartan | API Info | 
	Essential hypertension [ICD-11: BA00] | [114] | |||
| Dipyridamole | API Info | 
	Atherosclerosis [ICD-11: BA80] | [115] | |||
| Indapamide | API Info | 
	Essential hypertension [ICD-11: BA00] | [116] | |||
| Nebivolol | API Info | 
	Pulmonary hypertension [ICD-11: BB01] | [117] | |||
| Betaxolol | API Info | 
	Essential hypertension [ICD-11: BA00] | [118] | |||
| Eplerenone | API Info | 
	Ventricular dysfunction [ICD-11: BD13] | [119] | |||
| Methyldopa | API Info | 
	Essential hypertension [ICD-11: BA00] | [120] | |||
| Bisoprolol | API Info | 
	Essential hypertension [ICD-11: BA00] | [121] | |||
| Chlorothiazide | API Info | 
	Congestive heart failure [ICD-11: BD10] | [122] | |||
| Ranolazine | API Info | 
	Angina pectoris [ICD-11: BA40] | [123] | |||
| Eprosartan | API Info | 
	Essential hypertension [ICD-11: BA00] | [124] | |||
| Macitentan | API Info | 
	Pulmonary hypertension [ICD-11: BB01] | [125] | |||
| ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
| Clarithromycin | API Info | 
	Pneumocystis pneumonia [ICD-11: CA40] | [126] | |||
| Chlorpheniramine | API Info | 
	Allergic rhinitis [ICD-11: CA08] | [127] | |||
| Fexofenadine | API Info | 
	Allergic rhinitis [ICD-11: CA08] | [128] | |||
| Loratadine | API Info | 
	Allergic rhinitis [ICD-11: CA08] | [129] | |||
| Desloratadine | API Info | 
	Allergic rhinitis [ICD-11: CA08] | [130] | |||
| Budesonide | API Info | 
	Allergic rhinitis [ICD-11: CA08] | [131] | |||
| Levofloxacin | API Info | 
	Bronchitis [ICD-11: CA20] | [132] | |||
| Ceftibuten | API Info | 
	Bronchitis [ICD-11: CA20] | [133] | |||
| Levocetirizine | API Info | 
	Allergic rhinitis [ICD-11: CA08] | [134] | |||
| Ofloxacin | API Info | 
	Pneumocystis pneumonia [ICD-11: CA40] | [135] | |||
| ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
| Doxycycline | API Info | 
	Periodontal disease [ICD-11: DA0C] | [136] | |||
| Omeprazole | API Info | 
	Gastro-oesophageal reflux disease [ICD-11: DA22] | [137] | |||
| Bisacodyl | API Info | 
	Irritable bowel syndrome [ICD-11: DD91] | [138] | |||
| Pantoprazole | API Info | 
	Gastro-oesophageal reflux disease [ICD-11: DA22] | [139] | |||
| Meclizine | API Info | 
	Functional nausea/vomiting [ICD-11: DD90] | [140] | |||
| Lansoprazole | API Info | 
	Duodenal ulcer [ICD-11: DA63] | [141] | |||
| Ranitidine | API Info | 
	Gastric ulcer [ICD-11: DA60] | [142] | |||
| Esomeprazole | API Info | 
	Duodenal ulcer [ICD-11: DA63] | [143] | |||
| Bismuth subsalicylate | API Info | 
	Irritable bowel syndrome [ICD-11: DD91] | [144] | |||
| Ondansetron | API Info | 
	Gastritis [ICD-11: DA42] | [145] | |||
| Cimetidine | API Info | 
	Duodenal ulcer [ICD-11: DA63] | [146] | |||
| Rabeprazole | API Info | 
	Gastro-oesophageal reflux disease [ICD-11: DA22] | [147] | |||
| Dexlansoprazole | API Info | 
	Gastro-oesophageal reflux disease [ICD-11: DA22] | [148] | |||
| Alosetron | API Info | 
	Irritable bowel syndrome [ICD-11: DD91] | [149] | |||
| Dolasetron | API Info | 
	Functional nausea/vomiting [ICD-11: DD90] | [150] | |||
| Rolapitant | API Info | 
	Functional nausea/vomiting [ICD-11: DD90] | [151] | |||
| Granisetron | API Info | 
	Functional nausea/vomiting [ICD-11: DD90] | [152] | |||
| ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
| Pseudoephedrine | API Info | 
	Erythema multiforme [ICD-11: EB12] | [153] | |||
| Isotretinoin | API Info | 
	Acne vulgaris [ICD-11: ED80] | [154] | |||
| Demeclocycline | API Info | 
	Acne vulgaris [ICD-11: ED80] | [155] | |||
| Propantheline | API Info | 
	Excessive sweating [ICD-11: EE00] | [156] | |||
| Tretinoin | API Info | 
	Acne vulgaris [ICD-11: ED80] | [157] | |||
| ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
| Naproxen | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [158] | |||
| Indomethacin | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [159] | |||
| Diclofenac | API Info | 
	Knee osteoarthritis [ICD-11: FA01] | [160] | |||
| Etodolac | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [161] | |||
| Nabumetone | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [162] | |||
| Prednisone | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [163] | |||
| Cyclosporin A | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [164] | |||
| Risedronic acid | API Info | 
	Paget's disease [ICD-11: FB85] | [165] | |||
| Fenoprofen | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [166] | |||
| Flurbiprofen | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [167] | |||
| Oxaprozin | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [168] | |||
| Raloxifene | API Info | 
	Osteoporosis [ICD-11: FB83] | [169] | |||
| Leflunomide | API Info | 
	Rheumatoid arthritis [ICD-11: FA20] | [170] | |||
| ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
| Ibuprofen | API Info | 
	Dysmenorrhea [ICD-11: GA34] | [171] | |||
| Finasteride | API Info | 
	Prostatic hyperplasia [ICD-11: GA90] | [172] | |||
| Oxybutynin | API Info | 
	Overactive bladder [ICD-11: GC50] | [173] | |||
| Tamsulosin | API Info | 
	Prostatic hyperplasia [ICD-11: GA90] | [174] | |||
| Dutasteride | API Info | 
	Prostatic hyperplasia [ICD-11: GA90] | [175] | |||
| Trospium | API Info | 
	Overactive bladder [ICD-11: GC50] | [176] | |||
| Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
|---|---|---|---|---|---|---|
| G-protein coupled receptor (GPCR) | ||||||
| DBT Name: Adenosine receptor A3 (AA3R) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 9.3 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | AA3R_HUMAN | |||||
| DBT Name: Muscarinic receptor M1 (ACM1) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 2.6 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | ACM1_HUMAN | |||||
| DBT Name: Muscarinic receptor M2 (ACM2) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 1.3 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | ACM2_HUMAN | |||||
| DBT Name: Dopamine D3 receptor (DRD3) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 22 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | DRD3_HUMAN | |||||
| DBT Name: Histamine H3 receptor (HRH3) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 5.3 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | HRH3_HUMAN | |||||
| DBT Name: Thromboxane A2 receptor (TBXA2R) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 12 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | TA2R_HUMAN | |||||
| Oxidoreductase (ORase) | ||||||
| DBT Name: Prostaglandin G/H synthase 1 (COX-1) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 1 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | PGH1_HUMAN | |||||
| DBT Name: Prostaglandin G/H synthase 2 (COX-2) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 2.9 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | PGH2_HUMAN | |||||
| DBT Name: Cytochrome P450 3A (CYP3A) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Inhibition (tested by experiment) | [178] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN ; CP3A5_HUMAN ; CP3A7_HUMAN ; CP343_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [179] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN ; CP3A5_HUMAN ; CP3A7_HUMAN ; CP343_HUMAN | |||||
| DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 201 uM (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 400 uM (tested by experiment) | [181] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| Experiment (3) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Protein expression downregulation (tested by experiment) | [182] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| DBT Name: Cytochrome P450 2E1 (CYP2E1) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 225 uM (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2E1_HUMAN | |||||
| DBT Name: Cytochrome P450 2C9 (CYP2C9) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | EC50 = 374.2 uM (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2C9_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 40 uM (tested by experiment) | [181] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2C9_HUMAN | |||||
| DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 118.6 uM (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2CJ_HUMAN | |||||
| DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | EC50 = 486.4 uM (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP2D6_HUMAN | |||||
| DBT Name: Cytochrome P450 3A5 (CYP3A5) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 186.4 uM (tested by experiment) | [180] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A5_HUMAN | |||||
| Hydrolase (HDase) | ||||||
| DBT Name: Phosphodiesterase 3A (PDE3A) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 > 3 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | PDE3A_HUMAN | |||||
| DBT Name: Phosphodiesterase 4D (PDE4D) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 > 10 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | PDE4D_HUMAN | |||||
| Primary active transporter (PAT) | ||||||
| DBT Name: Multidrug resistance protein 1 (ABCB1) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 0.31 mg.mL-1 (tested by experiment) | [183] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | MDR1_HUMAN ; MDR3_HUMAN ; ABCB5_HUMAN | |||||
| Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Inhibition ratio = 60 % (tested by experiment) | [184] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | MDR1_HUMAN ; MDR3_HUMAN ; ABCB5_HUMAN | |||||
| Experiment (3) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Inhibition ratio > 250 % (tested by experiment) | [185] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | MDR1_HUMAN ; MDR3_HUMAN ; ABCB5_HUMAN | |||||
| Nuclear receptor (NR) | ||||||
| DBT Name: Estrogen receptor alpha (ESR1) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 > 10 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | ESR1_HUMAN | |||||
| DBT Name: Progesterone receptor (PGR) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | IC50 = 21 uM (tested by experiment) | [177] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | PRGR_HUMAN | |||||
| Cell line (CELL) | ||||||
| DBT Name: Colon cancer Caco-2 cells (Caco-2) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Biological Activity | Chylomicron secretion upregulation (tested by experiment) | [186] | ||||
| Tested Species | Homo sapiens (Human) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
